Best Sarcoma Immunotherapy Doctors Worldwide — TOP 49

Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.

• Authored over 40 research publications focusing on tumor biology and immunology.
• Former Head of Internal Diseases at Istanbul Okan University Faculty of Medicine.
• Held leadership roles in medical oncology at GATA Haydarpasa Training Hospital.
• Member of the Turkish Medical Oncology Association and European Head and Neck Society.

Prof. Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center, specializing in sarcoma immunotherapy with over 41 years of experience of focused experience.

• ESMO faculty member for sarcoma treatment
• Trained at Institut Gustave Roussy in Paris – Europe's leading sarcoma center
• Published extensively on immunotherapy approaches for rare sarcomas
• Head of Oncology Outpatient Clinic at Sourasky

Dr. Ronit El Hasid has performed 300+ bone marrow and umbilical blood transplantations for children at Dana Dwek Children’s Hospital.

• Head of Pediatric Oncohematology and Oncology Department
• Published 50+ papers and presented 40+ conference reports
• Member of American Association for Hematology
• Trained at City of Hope Hospital in Los Angeles

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Prof. Bozkurt specializes in pediatric sarcoma immunotherapy with training at world-leading institutions like Harvard's Dana-Farber Cancer Institute.

• Over 36 years of experience in pediatric oncology and bone marrow transplants
• Vice Director of the Stem Cell Transplant Unit at Medical Park
• Published 40+ research papers on pediatric oncology treatments
• Member of European Bone Marrow Transplant Group (EBMT)

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Dr. Osama Abdel Mohimen Mohamed leads the Hematology Unit at Shefaa Al Orman Oncology Hospital. He treats complex blood cancers, including leukemia, lymphoma, and myeloma. Dr. Mohamed is a member of the European Society for Medical Oncology. He also holds memberships in the American Society of Hematology and ASBMT.

• Specializes in chemotherapy, immunotherapy, and bone marrow transplantation.
• Manages aggressive acute leukemia and chronic blood disorders.
• Treats complications arising from various solid tumors.
• Works at an ESMO-accredited center that handles 6,000 patients annually.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.

• Holds personal certification from the European Society for Medical Oncology.
• Treats complex conditions, including stage 4 colon and lung cancers.
• Member of the Turkish Medical Oncology and Turkish Lung Cancer societies.
• Performs systemic therapies such as immunotherapy, targeted therapy, and chemotherapy.

Dr. Mustafa Solak specializes in sarcoma immunotherapy, bringing expertise from Hacettepe University and İstanbul Sisli Etfal Teaching and Research Hospital.

• Completed fellowship at Hacettepe University Cancer Institute
• Trained at The University of Texas MD Anderson Cancer Center
• Extensive experience in various cancers including sarcoma
• Works at Hisar Hospital Intercontinental, a leading oncology center

Associate Professor Oguzhan Babacan specializes in pediatric sarcoma immunotherapy with 28 years of experience in bone marrow transplantation at Hisar Hospital Intercontinental.

• Expert in allogeneic, autologous, and haploidentical hematopoietic stem cell transplants
• Subspecialized in Pediatric Hematology and Oncology at GATA Military Medical Faculty
• Focuses on leukemia, lymphoma, and solid tumors in children
• Active in healthy baby monitoring and vaccination programs

Dr. Seref Komurcu is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, lung, colorectal, and solid cancers. Dr. Komurcu holds both ECFMG and ESMO certifications. He previously served as a professor at Gülhane Military Medical Academy.

• Published over 110 scientific papers on cancer management.
• Provides immunotherapy, targeted therapy, and chemotherapy treatments.
• Member of the American Society of Clinical Oncology.
• Works at a clinic affiliated with Johns Hopkins Medicine.

Dr. Necdet Uskent is a medical oncologist and hematologist at Anadolu Medical Center in Istanbul. He was part of the pioneering team that performed Turkey's first bone marrow transplant. Dr. Uskent holds the European Medical Oncology Certificate and focuses on breast, lung, and gastrointestinal cancers. He works at a facility affiliated with Johns Hopkins Medicine.

• Founder of the Turkish Oncology Group (TOG).
• A founding member of the Turkish Society of Medical Oncology.
• Served as a visiting lecturer at Royal Free and University College Hospital in London.
• Treats complex hematological conditions including lymphomas and myeloma.

Dr. Dror Levin is a leading expert in sarcoma immunotherapy for children, coordinating treatment at Sourasky Medical Center.

• Senior pediatrician at Children's Hospital 'Dana'
• Director of children's hematology oncology department
• Specialized in pediatric hematology and oncology
• Studied sarcoma treatment at Rizzoli Orthopaedic Institute in Italy
• Member of Israel's pediatric hemato-oncology association

Dr. Nichakorn Seehirunwong is a diagnostic radiologist specializing in interpreting medical imaging for accurate sarcoma diagnosis and treatment planning.

• Graduated from Prince of Songkla University with an M.D.
• Holds a Certificate of Diagnostic Radiology from Prince of Songkla University
• Current diagnostic radiologist at Intrarat Hospital
• Specializes in comparing imaging results with other tests for comprehensive diagnosis
• Provides imaging-guided procedures for precise treatment guidance

Associate Professor with extensive experience across breast, lung, and gastrointestinal cancers at Istinye University Liv Hospital Bahcesehir.

• Specializes in complex cancer cases
• Promoted to Associate Professor in 2016
• Background in Internal Medicine at Malatya State Hospital
• Previously worked in Ankara Oncology Clinic
• Member of Oncology Department at Erzurum Regional Training and Research Hospital

Professor Cemil Bilir specializes in sarcoma immunotherapy with extensive academic and clinical experience in oncology.

• Board-certified in medical oncology with over 21 years of experience of experience
• Member of ASCO and ESMO – leading oncology societies
• Researched at Northeastern University's Center for Pharmaceutical Biotechnology and Nanomedicine
• Currently a professor at Sakarya University Faculty of Medicine

Dr. Alemdar specializes in sarcoma immunotherapy, bringing extensive training from Akdeniz University and experience at leading hospitals.

• Board-certified in medical oncology with a focus on sarcoma
• Over 20 years of experience of experience in oncology practice
• Worked at Akdeniz University Hospital and Antalya Training and Research Hospital

Professor of Medical Oncology with over 29 years of experience of experience – Dr. Cicin specializes in sarcoma immunotherapy at İstinye University Liv Hospital Topkapı.

• Fellowship-trained in Medical Oncology at Trakya University
• Former Associate Professor at Trakya University Faculty of Medicine
• Member of the Turkish Medical Oncology Association